AXM Pharma Key Fundamental Indicators
AXM Pharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from AXM Pharma's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting AXM Pharma's valuation are summarized below:AXM Pharma does not now have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. AXM |
Search Suggestions
| AX | Axos Financial | Company |
| AXS-PE | AXIS Capital Holdings | Company |
| AXBIX | Intermediate Term Tax Free Bond | Mutual Fund |
| AXDI | BlackRock | ETF |
| AXS | Axie Infinity Shards | Cryptocurrency |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, AXM Pharma has a Price To Sales of 1.0E-4 times. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
AXM Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AXM Pharma's current stock value. Our valuation model uses many indicators to compare AXM Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AXM Pharma competition to find correlations between indicators driving AXM Pharma's intrinsic value. More Info.AXM Pharma is rated second in profit margin category among its peers. It is number one stock in operating margin category among its peers reporting about 1.49 of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all technique that is used if you cannot value AXM Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.AXM Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AXM Pharma's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AXM Pharma could also be used in its relative valuation, which is a method of valuing AXM Pharma by comparing valuation metrics of similar companies.AXM Pharma is currently under evaluation in price to sales category among its peers.
AXM Fundamentals
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 28.73 M | |||
| Shares Outstanding | 10.41 B | |||
| Price To Sales | 0.0001 X | |||
| Revenue | 113.08 M | |||
| Gross Profit | 20.08 M | |||
| EBITDA | (9.43 M) | |||
| Net Income | 8.18 M | |||
| Cash And Equivalents | 1.66 M | |||
| Total Debt | 3.61 M | |||
| Debt To Equity | 0.63 % | |||
| Current Ratio | 0.70 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 34.76 M | |||
| Earnings Per Share | 0 X | |||
| Beta | -25.41 | |||
| Market Capitalization | 10.41 K | |||
| Total Asset | 104.43 M | |||
| Retained Earnings | (34.77 M) | |||
| Working Capital | (14 K) | |||
| Current Liabilities | 14 K | |||
| Z Score | 1.0 | |||
| Net Asset | 104.43 M |
Pair Trading with AXM Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AXM Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AXM Pharma will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to OReilly Automotive could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OReilly Automotive when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OReilly Automotive - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OReilly Automotive to buy it.
The correlation of OReilly Automotive is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OReilly Automotive moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OReilly Automotive moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OReilly Automotive can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in AXM Stock
If you are still planning to invest in AXM Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AXM Pharma's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |